Association of the –2849 interleukin‐10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis
Open Access
- 2 July 2003
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (7) , 1841-1848
Abstract
Objective: To analyze the –2849 A/G interleukin‐10 (IL‐10) promoter polymorphism, which is associated with high (AG/GG) and low (AA) IL‐10 production, in a cohort of rheumatoid arthritis (RA) patients and controls in order to gain a better understanding of its role in the incidence and progression of RA.Methods: Allele frequencies of the promoter polymorphism –2849 A/G and carriage rates were compared in 283 RA patients, 413 patients with other rheumatic diseases, and 1,220 healthy controls. The rate of joint damage and baseline levels of IgG and IgM rheumatoid factors and anti–citrullinated peptide antibodies were measured and were correlated with the IL‐10 gene polymorphism. Furthermore, the correlation between the invasiveness of fibroblast‐like synoviocytes (FLS) and the −2849 IL‐10 genotype was tested.Results: The IL‐10 genotype was not associated with the incidence of RA, but instead, correlated with disease progression, as determined by the extent of joint destruction. A higher rate of joint destruction was observed in patients with the genotype associated with high IL‐10 production. Since FLS are thought to be involved in joint destruction, we analyzed IL‐10 genotypes in conjunction with FLS invasiveness. Although adenoviral gene transfer of IL‐10 to FLS inhibited their invasiveness, no differences were observed in vitro in the FLS from RA patients who were –2849 non‐G carriers compared with those who were G carriers. Instead, patients with the –2849 AG/GG genotype, which is associated with high IL‐10 production, had higher autoantibody titers at baseline.Conclusion: The –2849 IL‐10 promoter polymorphism is associated with autoantibody production and subsequent joint damage in RA.Keywords
This publication has 33 references indexed in Scilit:
- Differential regulation of interleukin-10 production by genetic and environmental factors – a twin studyGenes & Immunity, 2002
- No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: the Leiden 85‐plus StudyEuropean Journal of Clinical Investigation, 2002
- Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory ArthritisScience, 2002
- Interleukin-10 and the Interleukin-10 ReceptorAnnual Review of Immunology, 2001
- Are differences in interleukin 10 production associated with joint damage?Rheumatology, 2000
- Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patientsArthritis & Rheumatism, 1998
- Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1996
- Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritisArthritis & Rheumatism, 1995
- PROGNOSTIC FACTORS IN RHEUMATOID ARTHRITIS. COMPARATIVE STUDY OF TWO SUBSETS OF PATIENTS ACCORDING TO SEVERITY OF ARTICULAR DAMAGERheumatology, 1995
- Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.Journal of Experimental Medicine, 1994